{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:37:35Z","timestamp":1778657855457,"version":"3.51.4"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["HEALTH-F2-2010-261358"],"award-info":[{"award-number":["HEALTH-F2-2010-261358"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000627","name":"Guarantors of Brain","doi-asserted-by":"publisher","award":["523410"],"award-info":[{"award-number":["523410"]}],"id":[{"id":"10.13039\/501100000627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189891","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T18:47:58Z","timestamp":1513968478000},"page":"e0189891","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Quantification of huntingtin protein species in Huntington\u2019s disease patient leukocytes using optimised electrochemiluminescence immunoassays"],"prefix":"10.1371","volume":"12","author":[{"given":"Davina J.","family":"Hensman Moss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael I.","family":"Scahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela A.","family":"Tessari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2716-2045","authenticated-orcid":true,"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length","volume":"22","author":"LP de Almeida","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"ref2","first-page":"323","article-title":"Huntington\u2019s Disease. Oxford Monographs on Medical Genetics","author":"A Hughes","year":"2014"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","author":"GP Bates","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"JS Paulsen","year":"2008","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"SJ Tabrizi","year":"2011","journal-title":"Lancet neurology"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"SJ Tabrizi","year":"2009","journal-title":"Lancet neurology"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"SJ Tabrizi","year":"2013","journal-title":"The Lancet Neurology"},{"key":"ref8","first-page":"RRN1184","article-title":"Observing Huntington\u2019s Disease: the European Huntington\u2019s Disease Network\u2019s REGISTRY","volume":"2","author":"M Orth","year":"2010","journal-title":"PLoS currents"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"CA Ross","year":"2014","journal-title":"Nature reviews Neurology"},{"key":"ref10","unstructured":"ClinicalTrials.gov. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington\u2019s Disease 2015 [updated March 2016]. A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 443139 in Patients With Early Manifest Huntington\u2019s Disease]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02519036\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02519036<\/ext-link>."},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"M Bjorkqvist","year":"2008","journal-title":"The Journal of experimental medicine"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1586\/14737175.8.12.1779","article-title":"Immune markers for Huntington\u2019s disease?","volume":"8","author":"E Wild","year":"2008","journal-title":"Expert review of neurotherapeutics"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","article-title":"Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression","volume":"122","author":"A Weiss","year":"2012","journal-title":"The Journal of clinical investigation"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1172\/JCI64484","article-title":"Mutant huntingtin impairs immune cell migration in Huntington disease","volume":"122","author":"W Kwan","year":"2012","journal-title":"The Journal of clinical investigation"},{"key":"ref15","first-page":"388","article-title":"Characterisation of immune cell function in fragment and full-length Huntington\u2019s disease mouse models","volume":"73C","author":"U Trager","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"e96854","DOI":"10.1371\/journal.pone.0096854","article-title":"Quantification assays for total and polyglutamine-expanded huntingtin proteins","volume":"9","author":"D Macdonald","year":"2014","journal-title":"PloS one"},{"key":"ref17","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"A Boyum","year":"1968","journal-title":"Scandinavian journal of clinical and laboratory investigation Supplementum"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0022-1759(87)90139-6","article-title":"Separation of human blood using \u2018mono-poly resolving medium\u2019","volume":"99","author":"Needham","year":"1987","journal-title":"J Immunol Methods"},{"key":"ref19","unstructured":"BD. BD Vacutainer<sup>\u00ae<\/sup> CPT\u2122 Cell Preparation Tube product information 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.bd.com\/vacutainer\/products\/molecular\/heparin\/\" xlink:type=\"simple\">http:\/\/www.bd.com\/vacutainer\/products\/molecular\/heparin\/<\/ext-link>."},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data","volume":"11","author":"SJ Tabrizi","year":"2012","journal-title":"Lancet neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nicl.2012.12.001","article-title":"Evaluation of multi-modal, multi-site neuroimaging measures in Huntington\u2019s disease: Baseline results from the PADDINGTON study","volume":"2","author":"NZ Hobbs","year":"2012","journal-title":"NeuroImage Clinical"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nsmb1234","article-title":"The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model","volume":"14","author":"P Li","year":"2007","journal-title":"Nature structural & molecular biology"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/hyb.2005.24.231","article-title":"Epitope mapping of monoclonal antibody 4C8 recognizing the protein huntingtin","volume":"24","author":"SY Cong","year":"2005","journal-title":"Hybridoma (2005)"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jmri.1880070620","article-title":"Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer\u2019s disease","volume":"7","author":"NC Fox","year":"1997","journal-title":"Journal of magnetic resonance imaging: JMRI"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.neuroimage.2009.06.003","article-title":"Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington\u2019s disease","volume":"47","author":"NZ Hobbs","year":"2009","journal-title":"NeuroImage"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00031305.1992.10475842","article-title":"A Note on the Delta Method","volume":"46","author":"GW Oehlert","year":"1992","journal-title":"The American Statistician"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","DOI":"10.1002\/ana.410410521","article-title":"CAG Repeat Number Governs the Development Rate of Pathology in Hungtington\u2019s Disease","volume":"41","author":"JB Penney","year":"1997","journal-title":"Annals of Neurology"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng0494-409","article-title":"Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm","volume":"6","author":"H Telenius","year":"1994","journal-title":"Nature genetics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2350-10-11","article-title":"DNA instability in replicating Huntington\u2019s disease lymphoblasts","volume":"10","author":"M Cannella","year":"2009","journal-title":"BMC medical genetics"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V28.3.455.455","article-title":"The intravascular lifespan of monocytes","volume":"28","author":"DM Whitelaw","year":"1966","journal-title":"Blood"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/4772","article-title":"Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans","volume":"5","author":"M Hellerstein","year":"1999","journal-title":"Nature medicine"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/icb.1997.69","article-title":"B cell life span: a review","volume":"75","author":"DA Fulcher","year":"1997","journal-title":"Immunology and cell biology"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of <italic>HTT<\/italic> generates the pathogenic exon 1 protein in Huntington\u2019s disease","volume":"110","author":"K Sathasivam","year":"2013","journal-title":"PNAS"},{"key":"ref34","article-title":"DNA Triplet Repeat Expansion and Mismatch Repair","author":"RR Iyer","year":"2015","journal-title":"Annual review of biochemistry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/jmg.30.12.982","article-title":"Gametic but not somatic instability of CAG repeat length in Huntington\u2019s disease","volume":"30","author":"ME MacDonald","year":"1993","journal-title":"Journal of medical genetics"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington\u2019s disease","volume":"19","author":"D Zielonka","year":"2013","journal-title":"Parkinsonism & related disorders"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/bj1910869","article-title":"Albumin obscures sex differences in blood protein patterns of rats and humans","volume":"191","author":"DM Gersten","year":"1980","journal-title":"The Biochemical journal"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-4825(84)90034-9","article-title":"Sex differences in blood protein patterns: a computer-assisted electrophoretic analysis of mid-molecular weight range proteins of human serum","volume":"14","author":"T Mahany","year":"1984","journal-title":"Computers in biology and medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T01:23:52Z","timestamp":1719710632000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189891"}},"subtitle":[],"editor":[{"given":"David R","family":"Borchelt","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189891","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]}}}